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What is Urban Health Policy and What's Law Got
To Do With It?
Larry I. Palmer*
''The experts concluded that if the community were to be healthy, if it were not
to revert again to a blighted or slum area, as though possessed of a congenital
disease, the area must be planned as a whole. It was not enough, they believed,
to remove existing buildings that were insanitary [sic] or unsightly." 1

More than half the world's population now lives in cities? Legal scholars are
beginning to explore the global implications of urban poverty on the .health of
various segments of the population. 3 Scholars from a variety of disciplines have
assumed that our domestic policy problems such as health disparities-however
defined-will be solved by enactment of various pieces of national legislation.
Even those whose ideological commitments lead them to favor "market-based"
solutions over government involvement in the "health care reform" debate
assume the need for national or state solutions in the form of tax incentives or
deregulation. 4
I propose to enrich scholarship and discourse on health policy by shifting the
focus away from global, national, and state action to that which is most
local-the neighborhood, the community, and the city. 5 Our public discourse no

* Professor of Law, The College of William & Mary School of Law. This Article was inspired by my
position as Distinguished Visiting Professor Law, O'Neil Center for Global and National Health,
Georgetown Law School, Fall 2007. I wish to acknowledge the students at Georgetown Law School in
my seminar, Emerging Problems of Urban Public Health, who raised many provocative questions about
my approach. I further wish to acknowledge the assistance of Juliana Frisch, The College of William &
Mary Law School Class of 2008 and Lea!I Kaufman, The College of William & Mary Law School Class
of 20 I 0 for their assistance with the footnotes. © 2009, Larry L Palmer.
1. Berman v. Parker, 348U.S. 26,34 (1954) (upholding the constitutionality of legislation authorizing
"urban renewal" that allowed a public condemnation of commercially "healthy" property to be turned
over to a private developer for demolition).
2. UNITED NATIONS POPULATION FuND, STATE OF WORLD POPULATION 2007: UNLEASHING THE
PoTENTIAL OF URBAN GROWTH 1 (2007), available at· http://www.unfpa.org/swp/2007/presskit/pdf/
sowp2007 _eng.pdf (last visited Nov. 9, 2008).
3. See generally Lawrence 0. Gostin, Meeting Basic Survival Needs of the Worlds Least Healthy
People Toward a Framework Convention on Global Health, 96 GEo. L.J. 331 (2008) (arguing in part that
the poorest people in the poorest countries have the worst health, and that this has effects across the
globe).
4. See, e.g., John McCain 2008, Straight Talk on Health System Reform, http://www.johnmccain.com/
lnformingllssues/19ba2flc-c03f-4ac2-8cd5-5cf2edb527cf.htm (last visited July 28, 2008).
5. What constitutes a city or urban area is a matter of state law in this country and has been recently
undergoing change as some traditional cities have combined with the surrounding counties to form
635
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longer embraces Justice Douglas' metaphor of the city as inherently sick as a
social and physical phenomenon, or, in his words, as "possessed of a congenital
disease." 6 We are just as likely to hear calls for a "new urbanism" that decries the
ill health consequences of "suburban sprawl" as a sort of panacea for a host of
health issues facing the nation. 7
Yet there are reminders of our lack of understanding about the nature of
modern urban living in the attempted rebuilding of parts of New Orleans and
other Gulf Coast cities after Hurricanes Katrina and Rita. In the immediate
aftermath of the flooding in 2005, it was as if the nation discovered for the first
time that there were poor people living beyond the French Quarter in New
Orleans. Old fashioned public health concerns-dean water, sewage, retrieval of
bodies, and so on-were the subject of the nightly news. 8 The term "refugees"
was used to describe residents of an American city when they sought reprieve
from rising flood waters. 9 Despite promises by politicians at all levels of
government to "rebuild" New Orleans, many of us wonder if a city with the
population and the ethnic, racial, and socio-economic diversity of New Orleans
as of August 2005 will ever exist again in our lifetimes. 10 Whatever the
demographic and physical layout of_ the "new" New Orleans, it is increasingly
clear that we do not understand how statutes, regulations, and court decisions at

metropolitan governments, such as in Louisville, Kentucky, Memphis, Tennessee, and Indianapolis,
Indiana. See IND. CoDE ANN. § 36-3-1-1 (LexisNexis 2008) (the merger of Indianapolis and Marion
County, known as UniGov, began in 1970 and was ordered by state legislation); KY. REv. STAT. ANN.
§ 67C.101 (LexisNexis 2008) (the merger of Louisville and Jefferson County began in 2003 via a ·
referendum, for which the legislature gave permission through special legislation); TENN. CODE. ANN.
§ 7-1-101(4), (5) (2007) (providing definitions for "metropolitan government" and "metropolitan
government charter commission"). See also FRANK GAMRAT & JAKE HAULK, ALLEGHENY INST. FOR PuB.
POLICY, MERGING GOVERNMENTS: LESSONS FROM LoUISVILLE, INDIANAPOLIS, AND PHILADELPIDA (2005),
available at http://www.alleghenyinstitute.org/reports/05_04.pdf (last visited Nov. 9, 2008) (providing
an overview of the processes in Louisville, Indianapolis, and Phihidelphia).
6. Berman, 348 U.S. at 34 (emphasis added).
7. See, e.g., Ernie Hood, Dwelling Disparities: How Poor Housing Leads to Poor Health, 113 ENVTL
HEALTH PERSP. A310 (2005); David E. Jacobs, Tom Kelly & John Sobolewski, Linking Public Health,

Housing, and Indoor Environmental Policy: Successes and Challenges at Local and Federal Agencies in
the United States, 115 ENVTL HEALTH PERSP. 976 (2007); Jennifer Medlin, Dwelling on Differences in
Health, 113 ENVTL HEALTH PERSP. A592 (2005).
8. See, e.g., Elizabeth Agnvall, Next Threat: Illness; Experts Anxious to Contain Disease Outbreaks,
Rumors, WASH. PosT, Sept. 13, 2005, at F01; Timothy Dwyer & Michael A. Fletcher, Residents Stay Put,
Despite Orders; Officials Warn of Floodwaters' Health Threat, WASH. PosT, Sept. 8, 2005, at A13;
Jessica Heslam, Katrina's Wrath: Health Crisis Looms in Bayou, BosTON HERALD, Sept. 1, 2005, at 2;
Robert D. McFadden & Ralph Blumenthal, Bush Sees Long Recovery for New Orleans, N.Y. TIMEs, Sept.
1, 2005, atA1; Bruce Nichols, Waterborne Bacteria Suspected in Some Deaths, DALLAs MORNING NEWS,
Sept. 8, 2005, at 1A; Jonathan D. Rockoff, Health Officials Focus on Infectious Diseases, BALT. SUN,
Sept. 7, 2005, at lOA.
9. See, e.g., Calling Katrina Survivors 'Refugees' Stirs Debate, AsSOCIA'!JlD PREss, Sept. 7, 2005,
available at http://www.msnbc.msn.com/id/92320711 (last visited Nov. 15, 2009).
10. Cf, e.g., Jenny Jarvie, A Fury in New Orleans as Housing Demolition Okd; Protesters, Police
Clash During a City Council Hearing Where a Plan to Raze Public Projects is Unanimously Approved,
L.A. TIMEs, Dec. 21, 2007, at A19; Adam Nossiter & Leslie Eaton, New Orleans Council Votes for
Demolition of Housing, N.Y. TIMEs, Dec. 21,2007, atA37.
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every level of government affect where people live and how that "built
environment" conditions individual and collective health risks. One symbol of
our concern for what is happening not only in New Orleans, but in many older
cities 11 across this country, is the indefinite closure of Charity Hospital-often
called Big Charity for its public service to the poor-in New Orleans. 12
I propose to -shed light on analytical methods likely to generate solutions to
post-Katrina confusion by focusing on.a question: What is urban health policy?
This question is useful in the current era when many assume that anything not
based on science or black-letter legal precedent should be lumped under the
vague rubric of "policy." This misconception assumes "values" or "emotions" 13
are the primary drivers of decision-making. When this notion is applied to health
policy, we further make a normative assumption that different perspectives on
health risk are best navigated by the political and regulatory processes and
avoided by courts. My answer here is grounded in the scholarship of institutional
choice. 14 Using a form of comparative institutional analysis, I will also answer
the subsidiary question of what role law plays in urban health policy by
illustrating how various Iegai institutions-courts, legislatures, regulatory bodies
of various kinds-and "the market" become the primary forum for policymaking. Such an analytical approach may assist us to see the limits of law in
some instances, but also illuminates instances in which the law has provided
incentives for social and economic institutions adverse to the health and
well-being of the most vulnerable in our urban communities. Ultimately, my
analysis emphasizes that lawyers should view health policy discourse as
intrinsically multidisciplinary, even when we are engaged in litigation before
courts.
My analysis is in four parts. Part I develops a framework for defining urban
health policy in· the context of an institutional analysis of law. I propose that the

11. None of MONEY Magazine's ten best cities to live in are what I would refer to as an "older city."
See Kate Ashford, eta!., Best Places to Live, MoNEY, Aug. 2007, available at http://money.cnn.com/
galleries/2007/moneymag/0707/gallery.BPTL_top_lOO.moneymag/index.htrnl (last visited Nov. 9, 2008)
(reporting that the ten best cities are Middleton, Wisconsin, Hanover, New Hampshire, Louisville,
Colorado, Lake Mary, Florida, Claremont, California, Papillion, Nebraska, Milton, Massachusetts,
Chaska, Minnesota, Nether Providence, Pennsylvania, and Suwanee, Georgia).
12. For more about the closure of public hospitals in Louisiana, see generally Elizabeth A. Weeks,
Shaping A New Direction for Law and Medicine: An International Debate on Culture, Disaster,
Biotechnology and Public Health, 10 DePaul J. Health CareL. 251 (2007). For more on the closure of
public hospitals as a general matter, see generally Julie J. Piotrowski, How Secure is the Safety Net?
Public Hospitals Learn to Survive in an Increasingly Tight Market by Closing, Building, Replacing, and
Sometimes Converting, Modem Healthcare 32, no. 8 (2002).
13. Cf MARTHA NUSSBAUM, UPHEAVALS OF THOUGHT: THE INTELLIGENCE OF EMOTIONS 420-25 (2001)
(arguing that empathy could influence the way judges construct issues).
14. See generally, e.g., NEIL K. KOMESAR, LAW'S LIMITS: THE RULE OF LAW AND TilE SUFPLY AND
DEMAND OF RIGHTS (2001); William W. Buzbeee, Sprawl's Dynamics: A Comparative Institutional
Critique, 35 WAKE FoREST L. REv. 509 (2000). See also Nancy J. Knauer, The Recognition of Same-Sex
Relationships: Comparative Institutional Analysis, Contested Social Goals, and Strategic Institutional
Choice, 28 U. HAw. L. REv. 23 (2006).
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Supreme Court's opinion in Berman v. Parker 15 illustrates the continuing debate
over the role courts play in shaping the built environment of cities in the United
States. Relying solely on the analysis of courts as emblematic of the Rule of Law,
however, ignores the dynamic nature of the impact that legal institutionsincluding courts at the local and state level, as well as political bodies at various
levels of government-have on shaping the social ecology of American cities,
together with social and demographic factors. Combining a market analysis with
a systemic approach to analyzing the impact that legal institutions have on that
market produces a set of empirical questions all legal institutions must address.
The dearth or uncertainty of data central to a particular issue is not a limitation
that affects only the courts; it impacts political bodies as well. 16
Part II uses this institutional definition of urban health policy to analyze the
problem encountered by researchers conducting empirical studies about "healthy"
and "unhealthy" housing. There has been considerable commentary on litigation
over attempts to find cost effective means to eliminate health risks posed by lead
paint in older urban dwellings. 17 What has not been fully discussed is the ongoing
shift in how we frame the problem of unhealthy housing in. urban areas. Rather
.than seek the surgical removal of blighted housing, as was done in the era of
urban renewal, the emphasis has shifted to "curing" lead-laden housing of its
illness. This new emphasis on restoring existing housing stock comes at a time
when the federal government is supporting the replacement of older public
housing projects with mixed income housing. 18 In addition, little attention has
been paid to the response of other institutions to the Maryland court's decision in
Grimes v. Kennedy Kreiger, which held that a research organization could be
liable for a faulty consent process in lead paint research. Kennedy Krieger has
negatively impacted the ability of empirical scientists to gather data on the effects
housing has on its residents. Political bodies have responded to the opinion, but
not in the way desired by in the dissent in Kennedy Kreiger, or by public interest
parties involved in the case. 19 Of even greater significance is the response of the
research community and its allies in the federal agencies that fund most housing

15. See generally Berman, 348 U.S. 26.
16. See KOMESAR, supra note 14.
17. See Grimes v. Kennedy Krieger Inst., Inc., 782 A.2d 807 (Md. 2001). Most legal commentary on
Kennedy Krieger focuses on bioethical issues, informed consent, and experimental procedures. See, e.g.,
Carl H. Coleman, Duties to Subjects in Clinical Research, 58 VAND. L. REv. 387,431-32 (2005); Doriane
Lan~belet Coleman, The Legal Ethics of Pediatric Research, 57 DuKE L.J. 517, 523-603 (2007); Russell
Korobkin, Autonomy and Informed Consent in Nontherapeutic Biomedical Research, 54 UCLA L. REv.
605,614 (2007).
18. See, e.g., U.S. Department of Housing and Urban Development, HOPE VI, http://www.hud.gov/
offices/pih/programs/phlhope6/ (last visited Nov. 9, 2008). For a critique of HOPE VI, see NATIONAL
HOUSING LAW PROJECT, ET AL., FALSE HOPE: A CRrnCAL ASSESSMENT OF THE HoPE VI PuBuc HOUSING
REDEVELOPMENT PROGRAM (2002).
19. Kennedy Krieger, 782 A.2d at 862 (Raker, J., dissenting) (arguing that the issue of a parent or
guardian' ability to consent to the participation of a minor child in a nontherapeutic research study is an
important public policy consideration best dealt with by the legislature).
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research. Once again, the response differs from what researchers and research
organizations involved in Kennedy Krieger might have wanted. 20 This more
nuanced analysis of the various institutional actors involved in healthy housing
problems illustrates that a new actor--one for the moment identified as "the
community"-must become involved, not only in creating solutions to the
healthy housing problem, but also in formulating the research questions
themselves? 1 More generally, I contend that the shift in framing the healthy
housing problem, from surgical cure to renewal and restoration of a community,
illustrates that policy development and policy-making are two different types of
processes in public health systems.
Part ill uses the legislative debate over mandating the Human Papillomavirus
(HPV) vaccine and the New York City?s diabetes surveillance regulations to
argue that the legal tools of the "old public health" will not be effective in the
"new public health" milieu?2 Noble goals, such as ensuring the most vulnerable
populations receive vaccination or optimal diabetes management, by themselves
will not solve the complex questions of whether law, in whatever form, does or
can achieve the optimal amount of health in an urban population, or any subgroup
within that population. The new public health is not simply a matter of public
health officials assuming new conditions to be within the purview. of their
expertise or function. Rather, the science underlying public health must now
incorporate the new knowledge generated by genomics?3 An HPV vaccine
represents a new definition of how to interrupt the disease process that would not
have been possible prior to the Human Genome Project. 24 Furthermore, the
global social and economic systems render the traditional public health toolslegal isolation and quarantine--of limited utility as old diseases such as
tuberculosis evolve. My critique points to the need for a new legal framework
rather than the traditional balancing of interests analysis?5

20. See generally ETIIICAL CONSIDERATION FOR REsEARCH ON HOUSlNG RELATED HEALTH HAzARDS
lNVOLYlNG CHILDREN (Bernard Lo & Mary Ellen O'Connell eds., 2005).
21. See generally DA VYDD GREENWOOD & MORTEN LEYlN, INTRODUCTION TO ACTION REsEARCH:
SociAL REsEARCH FOR SOC1AL CHANGE (2nd ed. 2007).
22. The "new" public health has been characterized as a broad-based private and public effort to
reduce the social burdens of disease, including chronic diseases such as diabetes, obesity, and cancer.
Compare Richard A. Epstein, Let the Shoemaker Stick to His Last: A Defense of the "Old" Public Health,
46 PERSP. BIOLOGY & MED. 5138, 5139 (Supp. 2003) (arguing against broad regulatory intervention in
areas of public health outside traditional notions of infectious diseases and epidemics) with Lawrence 0.
Gostin & M. Gregg Bloche, The Politics of Public Health: A Response to Epstein, 46 PERSP. BIOLOGY &
MED. S 160, S 163-165 (Supp. 2003) (arguing that regulatory intervention is justified if there is strong data
suggesting the need for far-reaching public health interventions).
23. See generally, WHO WlLL KEEP THE PuBLIC HEALTHY?: EDUCATING PuBLIC HEALTH PROFESSIONALS FOR THE 21sr CENTURY (Kristine Gebbie et al. eds., 2002).
24. See Larry I. Palmer, Disease Management and Liability in the Human Genome Era, 47 VlLL. L.
REv. 1, 2 (2002).
25. Cf AmyL. Fairchild, Diabetes and Disease Surveillance, 313 SCIENCE 175, 176 (2006) (arguing
for a gloss on traditional balancing of privacy and public health by suggesting a distinction between soft
and hard paternalism).
·

640

The Georgetown Journal on Poverty Law & Policy

[Vol. XV

Part IV uses the problem of cardiovascular research and risk to illustrate that
health policy must incorporate social and economic costs into its legal analysis
without falling victim to the false promises of "consumer driven health care."26
Cardiovascular treatment and prevention is an area of health care delivery whose
cost effectiveness has been studied extensively, perhaps because of the rate of
innovation in the field as a consequence of new drugs, surgical techniques, and
devices for assisting or replacing heart functions? 7 On the other hand, many of
the conditions affecting vulnerable urban populations-for instance, obesity and
diabetes~increase the risk of cardiovascular disease. Therefore, framing the
problem mote broadly as cardiovascular risk and research allows for consideration of these additional factors in determining what data is needed to arrive at an
effective policy. 28 The most important insight from this application of comparative institutional analysis to a problem in urban health is the discovery that
attempts to measure "cost" should be replaced by efforts to measure "value" to
·
patients?9
I. Do CITIES

MAKE PEOPLE HEALTHIER?

At the tum of the last century, industrial cities were the antithesis of a healthy
built environment. The relatively well-off among city dwellers retreated to their
summer places for fresh-and presumably cleaner and healthier-air. This literal
and imaginative escape from the social and ecological lows of cities-polluted
air, crime, overcrowded housing, and traffic congestion-led to two parallel
. movements after World War II: urban renewal (the destruction of older residences
and businesses and their replacement by new construction), 30 and a strong
preference among Americans for suburban living away from urban centers.
Early migration from the urban center was built around rail (streetcar)
transportation during the early twentieth century. 31 Transportation technology-

26. See generally, CONSUMER-DRIVEN HEALTH CARE: IMPLICATIONS FOR PROVIDERS, PAYERS AND
PoLICY MAKERS (Regina E. Herzlinger ed. 2004). Herzlinger argues that consumer control will "reward
innovative insurers and providers for creating the higher-quality, lower-cost services we want and
deserve. In this consumer-driven system, government will protect us with financial assistance and
oversight, not micromanagement." /d. at xvii.
27. The AbioCor implantable heart is only the latest in a long list of cardiac assist devices. See, e.g.,
AbioMed, http://www.abiomed.com/products/index.cfm (last visited Nov. 9, 2008).
28. We should be mindful that determining what data to use in studies of health disparities generally is
itself a problem for researchers and policy makers. See Risa Lavizzo-Mourey & James R. Knickman,
Racial Disparities-The Need for Social Action, 349 NEw ENG. J. MED. 1379, 1380 (Oct. 2. 2003).
29. See MICHAEL E. PORTER AND ELIZABETH OLMSTED Th:ISBERG, REDEFlNlNG HEALTH CARE 97, 99
(2006).
30. For a short overview of the legislative and legal history of "fighting blight," see Colin Gordon,
Blighting the Way: Urban Renewal, Economic Development, and the Elusive Definition of Blight, 31
FORDHAM URB. L.J. 305,311-312,315 (2004).
31. See, e.g., The Official Website for the City of Richmond, VIrginia, Department of Economic
Development, http://www.richmondgov.com/departrnents/econdev/mbe/history.aspx (last visited Nov. 9,
2008) (pointing out that Richmond, Vrrginia had the world's first successful electric street car system).
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particularly the widespread use of the automobile-along with a number of
changes in federal, state, and local zoning laws surrounding the· financing of
highways, the construction of new housing, and the uses of land gave rise to the
current social and demographic structure of the suburbs. Zoning law-something
that is almost always a matter of local control-is one of the chief vectors
enabling development of the modem suburban subdivision. Single use zoning
gave rise to suburbanizing developments like the archetypal Levittown, Long
Island, where the mixed-use buildings so common in urban settings, such as
residential space above a retail establishment, were prohibited in favor of
single-use structures. 32 Embedded within zoning laws were social policies that
contrasted with the goal of the city as a center of economic, social, racial, and
ethnic diversity. 33 Justice Douglas, writing on behalf of the Supreme Court in
1974, concluded in Village of Belle Terre v. Boraas that a local zoning ordinance
limiting the number of unrelated persons living in a single "family" residence
was constitutional. 34 Justice Douglas was perhaps imagining a community that
was not a city, but a "village" that could use the local political process to preserve
a certain commonality among residents. At. a technicalleve( the Court held only
that local government has enough latitude under the Constitution to develop a
statutory definition of "family" that applied only to zoning laws. 35 More broadly,
the decision indicated that local political processes would be the locus of
decision-making for what public health scholars now identify as the "built
environment." 36
Justice Marshall's dissent in Belle Terre foresaw many social disadvantages of
the opinion's vision of community. The victims of "family zoning" in the case
before the court were college students seeking to rent a house. Justice Marshall
perceived the potential impact of the decision on the disadvantaged or members
of minority groups who might seek to live in a given "village.'m A plurality of
the Court in a subsequent case, Moore v. City of East Cleveland, Ohio, found it
unconstitutional to apply a "family zoning" ordinance in such a way as to force a
grandmother to remove one of her two grandsons, who were cousins rather than
brothers, from her dwelling. 38 Had the court ruled otherwise, the Moore family
would have been tom apart because it.did not fit a very constrained definition of
"family." One reason why courts might be reluctant to delve into underlying

32. See, e.g., Joshua Ruff, Levittown: The Archetype for Suburban Development, http://www.
historynet.comllevittown-the-archetype-for-suburban-development.htm (last visited Nov. 9, 2008); Matt
Rosenberg, Levittown, http://geography.about.com/od/urbaneconomicgeography/a!levittown.htm (last
visited Nov. 8, 2008).
33. This vision of the city may not be that shared by everyone, and may in fact be contrary to some
notions of community and neighborhood as articulated in community action research literature.
34. Belle Terre v. Boraas, 416 U.S. 1 (1974).
35. /d. at 8.
36. See, e.g., KOMESAR, supra note 14.
37. Belle Terre, 416 U.S. at 16-17 (Marshall, J., dissenting).
38. Moore v. City of East Cleveland, 431 U.S. 494 (1977) (Powell, J., plurality opinion).
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social issues in such zoning cases, however, is that the emotional-and therefore
the political-impact of zoning decisions can be painfully intense because they
impact in very fundamental way the manner in which people live and their sense
of home, as well as, in some cases, homelessness.
I suggest that most people concerned about poverty do not want to default to
some notion of the "market" or the old public health law paradigm39 for
determining where people live. We are becoming more aware of how thehousing
market is currently structured by existing regulation as well as by deregulation. 40
We know that how individuals live is a combination of individual preference,
economic and social conditions, and complex legal structures. We also know that
how and where people live has some impact on their health-mental and
physical. 41 We have, however, neither a systemic way of thinking about the
health impacts of living conditions nor the role of law or legal institutions in
. defining those living conditions. This problem is symbolized by the variety of
meanings we attribute to the term "health policy." The term could encompass
everything from some idealized process in which policy makers use scientifically
developed data to guide their decisions, to the often contentious process of
obtaining local zoning variance for a home for the mentally disabled, or repealing
the "tax subsidy" for health insurance prerniums. 42 All disciplines, but in
particular legal professionals, need to develop a clear definition of health policy.
I propose a broader definition of health policy: It includes any attempt by
private or public actors to shape the framing and resolution of decisions of
institutional actors-the market, political processes, regulatory and administrative processes, and courts-in the health system. The health system includes all
processes that support health in a given society. It has two important subsystems,
the health care delivery system and the public health system, which are of
particular significance to the construction of the legal system. Urban health
policy is thus defined by the conduct of institutional actors who influence the
health systems of particular communities. I will illustrate how the growth in
knowledge regarding health has changed the way that legal institutions respond
to urban health issues. At the same time, I will delineate the role of regulatory
agencies, legislatures and courts in developing health policy for urban areas. The
role" of these legal institutions varies depending upon the particular locality's
markets, political structures, and cultures, and the nature of the problem being
addressed. I began with the problem of healthy housing because institutional

39. See generally Esptein, supra note 22.
40. The current mortgage crisis is an example of this understanding. Cf Emergency Economic
Stabilization Act of 2008, HR 1424 (providing the federal government with authority to purchase certain
"troubled assets" related to the mortgage crisis).
41. There is plenty of evidence to support these intuitive assumptions, but this evidence is at best at the
level of proving an "association" between living conditions and health. The gold standard of "causation"
in public health sciences has not been met.
42. See generally Mark V. Pauly, Blending Better Ingredients for Health Reform, Health Affairs 27,
no. 6 (2008).
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actors at every level-state, local, national, and even global43-have some
influence on the framing and optimizing of solutions.

II.

POLICY CHOICE:

THE ROLE OF COURTS IN CREATING HEALTHY HOUSING

The health risks created by lead paint in older housing stock are now a major
issue in older cities. For instance, federal regulations prohibit the use of lead
painting in residences built after 1978.44 Such regulations impose costs, leading
some to argue that overregulation could impact the market by encouraging
landlords to simply abandon older housing with lead paint. This regulatory and
economic background provides part of the context for the case of Grimes v.
Kennedy Krieger Institute, 45 where the court held that a research organization
could be liable for failures in the consent process in what I will call "healthy
housing research."
I frame Kennedy Krieger as a healthy housing research case rather than a case
about "bioethics" or "public health ethics" for several reasons related to
scholarship on institutional choice. 46 First and foremost, scholarship on comparative institutional analysis often starts with a case concerning with liability. These
liability cases illustrate the need for courts to determine which institution is
best-positioned to take responsibility for abating risk. The most famous of these
cases, Boomer v. Atlantic Cement Company, 47 involves what we might call a
public health problem in that the plaintiff landowners claimed the pollution from
the plant created health risks to them. When the court ruled that the remedy for
nuisance would be damages rather than an injunction, the court was suggesting
that pollution (more broadly speaking, environmental health) was now a problem
for political institutions rather than for courts. 48 Thus, invoking a liability case to
illustrate the analytical advantages of comparative institutional analysis is a
technique used by many scholars following this approach to law and economics.
It should be noted, however, that few scholars have used this approach on

43. The sub-prime mortgage crisis is simply an illustration of how the financing of housing has
become a global enterprise. See Martin Fackler, Global Finance Leaders Warn of Risk from U.S. Housing
Woe, N.Y. TiMEs, Feb. 10,2008, atA16; MarkLandler, Housing Woes in U.S. Felt Around the Globe, N.Y.
TiMEs, Apr. 14, 2008, at AI.
44. Ban of Lead Containing-Paint and Certain Consumer Products Bearing Lead Containing-Paint, 16
C.F.R. § 1303 (2008). See also, Residential Lead-Based Paint Hazard Reduction Act of 1992,42 U.S.C.
§ 4851 (1992); 105 MASS. CODE REGS. 410.502 (2008).
45. Kennedy Krieger, 782 A.2d 807. Part of the analysis developed in this paper started with my
previous work, Larry I. Palmer, Genetic Health and Eugenics Precedents: A Voice of Caution, 30 FLA. ST.
U. L. REv. 237, 241-52 (2003), but without the emphasis on the heed to build costs into the framework
argued for in this paper.
46. See KOMESAR, supra note 14.
47. See generally Boomer v. Atlantic Cement Co., 257 N.E.2d 870 (N.Y. 1970).
48. See KOMESAR, supra note 14, at 12-26 for an extensive discussion of this case and its implications
for comparative institutional analysis.
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problems of the health system.49
Second, starting the analysis with Kennedy Krieger facilitates an explicit
discussion of goals in legal and health policy analysis. One of the mantras of
comparative institutional analysis is that social goals or values provide insufficient explanations for how institutional processes, including courts, operate.·
Public health law, and in the case of Kennedy Krieger, public health research, is
full of individuals with noble goals, which in the course of litigation are labeled
pejoratively as having "conflicts of interests." I will illustrate that courts are in
fact engaged in more than a hindsight analysis of the ethics of particular
individuals or organizations or "balancing of interests." Rather, my analysis of
Kennedy Krieger demonstrates that the various public and private individuals
caught up in the court's process of adjudication are best characterized as "good
people, operating under bad institutional arrangements."50
Third, using a case provides a more nuanced understanding of the role _for
courts in the debate over "who decides." Comparative institutional analysis is, in
part, a critique of the over-emphasis in legal scholarship and education on the role
of courts in resolving important social problems. On the other hand, courts are
arguably the best (or the least bad) forum for framing, if not resolving, some
controversial issues. I have argued, for example, that the abortion issue, or as I
prefer to frame it, the issue of family formation, is for courts, acting as
constitutional adjudicators, despite the deep religious and values conflict about
the appropriateness of termination of pregnancy in particular. 5 1 Just because the
United States Supreme Court frames the issue of family formation does not mean
that the political process or state courts do not participate in constricting family
formation decisions. 52 Thus, Kennedy Krieger illustrates a situation in which
state courts use common law notions of "duty" to allow disadvantaged urban
dwellers to question the control of the "health knowledge market" by professionals and their organizations. By signaling that "market failures"-inadequate
informed consent processes-might lead to court intervention, the court turns a
new page in the debate about who should decide whose health is put at risk to
discover the most cost efficient means of reducing health risks to a certain
community. Rather than think of the case as a failure· to obtain appropriate
informed consent, institutional analysis suggests this is a case about the duty to
49. The issues of property law and the law of damages tends to dominate the scholarship on
comparative institutional analysis, although Komesar acknowledges the applicability of the approach to
health related issues. See his citation of my patient safety work in Law's Limits. KOMESAR, supra note 14,
at 177. Even scholars concerned about the health of disadvantaged community frame the issues from the
perspective of property law and the law of remedy. See, e.g., Rachel D. Godsil, Viewing the Cathedral
from Behind the Color Line: Property Rules, Liability Rules and Environmental Racism, 53 EMORY L.J.
1807 (2004).
50. Larry I. Palmer, Paying for Suffering: The Problem of Human Experimentation, 56 MD. L. REv.
604, 611 (1997).
51. See LARRY I. PALMER, ENDING AND BEGINNINGS: LAW, MEDICINE & SOCIETY IN ASSISTED LIFE AND
DEATH 45-51 (Praeger Publishers 2000).

52. /d.

No.3]

What is Urban Health Policy

645

disclose certain information.
Looking at the "facts" of Kennedy Krieger through the lens of institutional
analysis encourages us to broaden the context before looking at the very narrow
issue decided in the case. 5 3 But first consider the facts from the perspective of the
narrowest legal question presented: Did the lower court err in granting summary
judgment for the defendant under the facts as alleged by the plaintiffs? As the
court described the issue:
Was the trial court incorrect in ruling on a motion for summary judgment that as
a matter of law a research entity conducting an ongoing non-therapeutic
scientific study does not have a duty to warn a minor volunteer participant
and/or his legal guardian regarding dangers present when the researcher has
knowledge of the potential for harm to the subject and the subject is unaware of
the danger? 54

There are a number of facts essential to answering this narrow question. The
Kennedy Krieger Institute undertook a study to find the most cost-efficient way
of reducing the health risks of lead paint in residences in the city of Baltimore.
The study required the periodic testing of levels of lead present in the dwellings
and as well as the levels of lead present in the blood of the children living in the
dwellings. The plaintiffs were children whose lead blood level was at the "normal
level" as determined by the guidelines developed by the Centers for Disease
Control and Prevention (CDC). 5 5 These blood levels became above normal after
testing indicated there was lead paint or "hot spots" in their dwellings. 56 There
was a delay between Kennedy Krieger's receipt of the blood test results and their
communication of the results to the parents or guardians of the plaintiffs. The
court concluded that the Kennedy Krieger Institute might have a duty to warn the
parents of their children's individual health risks discovered in the course of a
lead paint abatement study involving their residences. 5 7
As noted previously, there is considerable commentary on the court's broad
discussion of the regulatory oversight of the research process. 5 8 Unlike many of
those commentators, I believe the court understood that it was dealing with a
major problem in urban health policy and sought to frame the debate about
"healthy housing," not simply for courts, but for other institutions-legislatures,

53. The dissenting judge proposes a narrow framing of the issue on the theory that the legislature
ought to deal with the complexity of ethics and research policy implicit in the majority's ruling on
summary judgment. What the legislature in fact did after the case, as will be discussed infra may indicate
that majority was more aware of where the political process was on this type of research than the dissent.
See Kennedy Krieger, 782 A.2d at 862.
54. ld. at 818.
55. /d. at 825.
56. /d.
57. /d. at 818-19.
58. See sources cited in supra note 17.
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regulatory bodies, and the professionals engaged in the knowledge market. The
case is significant because the court explains the complexity of the problem in a
way that establishes a role for courts without implying that a court can solve the
healthy housing problem. Consider some of the salient things we discovered
about the participants in the market and political processes surrounding lead in
houses in the city of Baltimore.
In our modem era, governmental agencies provide funds for research
regarding many problems facing society. By the 1990s, federal and state agencies
had concluded it was not economically feasible to remove all lead paint from
older housing stock. 59 Some of those agencies prov_ided the funds for Kennedy
Krieger's research and helped individual researchers at Kennedy Krieger to
develop a complex research network. The Environmental Protection Agency
(EPA) provided a grant to the.Kennedy Krieger Institute to pay for some of the
researchers' time as well as other expenses of the project. 60 The two lead
researchers on the projects held appointments· at Johns Hopkins Schools of
Medicine and Public Health, 61 ·and ·the Institutional Review Board at Johns
Hopkins, apparently under contract, conducted the human subject review
required by federal regulations for the Kennedy Krieger Institute. 62 The
researchers needed additional organizational partners to conduct this complex
project because they needed to have dwellings with different levels of lead
abatement and families with children living in those dwellings.
To achieve these goals, the researchers facilitated loans from the Maryland
Department of Housing and Community Development to landlords63 and enlisted
a not-for-profit organization to assist with the recruitment of families with
children to live in the various housing units. 64 There was a Lead Hazard
Abatement Research Department at Kennedy Krieger in 200265 and the Institute
was the major center for testing for lead poisoning in Maryland and surrounding
states. The individual researchers were thus able to act as "knowledge entrepreneurs" prior to the litigation partially because of their affiliation with an
organization that took a systemic approach to the problem of childhood
disabilities of all kinds, including the disabilities caused by lead poisoning. In
many respects, this is the kind of public health research one might want to

59. One does not have to accept this statement as the empirical truth to accept this statement as part of
the context of the research. In point of fact, the researchers involved in this study had received a previous
grant on lead abatement that led to the grant at issue in the case. See Larry I. Palmer, Genetic Health and
Eugenics Precedents: A Voice of Caution, 30 Fla .. St. U.L Rev. 237, 245 (2003). ·
60. Kennedy Krieger, 782 A.2d at 819.
61. Palmer, supra note 59, at 250.
62. Kennedy Krieger, 782 A.2d at 811-12.
63. /d. at 820.
64. /d. at 819. See also, Lead Paint Poisoning of Children: Progress and Misplaced SelfCongratulation, EJ ACTIVIST (The Sierra Club, Prescott, Ariz.), Oct. 2004, at 1-2, available at
http://www.sierraclub.org/ej/downloads/Oct_2004.pdf (last visited Nov. 9. 2008) (discussing various
·
approaches to lead abatement).
65. Palmer, supra note 59, at n. 67.
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encourage since it is so steeped in the practical problems policy makers face.
Presumably, the more economical the means of removing lead to label housing
"healthy," the more healthy housing would be available for low-income renters.
Despite these noble goals, the courts used the case to make two institutional
points. First, the regulatory framework for human subjects established by the
federal government had failed, in the court's view, perhaps because it had been
captured by the researchers themselves. The court spent considerable time
analyzing and critiquing the working of the Institutional Review Board at Johns
Hopkins66 and was perhaps even aware of the fact that Johns Hopkins' internal
regulatory process for protecting subjects of research had been recently criticized
by the federal government. 67 The dissent and concurring judge invited the
legislature to join the discussion by narrowing the scope of the court's opinion. 68
The state legislature did react to the decision, but not in the way the researchers or
the dissent and concurring judges might have wanted. The legislature sought to
create public awareness of the working of IRBs by requiring minutes of
institutional review boards, with the names and other private information
redacted, to be made available to the public after those meetings. 69 Thus, one
aspect of the political regulatory process in effect affirmed the idea that
something was malfunctioning in the research regulatory system and sought not a
solution., but more data or knowledge about the actual process.
The other participants in the knowledge-creation market, the research community engaged in housing research, were in fact quite upset by the court's ruling
and convinced the three major funders of this type of research to fund a study.
The U. S. Department of Housing and Urban Development, the CDC, and the
EPA requested that the National Research Council and the Institute of Medicine
of the National Academic of Sciences conduct a study entitled "Ethical
Considerations for Research on Housing-Related Health Hazards Involving
Children. " 70 One recommendation of the study provides additional post-litigation
evidence that something is awry with the research oversight process. The report suggests that the "community" should be involved in the design of the
health-related housing research. 71 The ~mplication of this recommendation is that
the professionals must lose their monopoly on knowledge-creation in the healthy
housing debate in line with other recommendations to "democratize the research
process,'.n particularly as it relates to low-income residents.

66. Kennedy Krieger, 782 A.2d at 849-52.
67. See Palmer, supra note 59, at n. 81.
68. Kennedy Krieger, 782 A.2d at 862 (Raker, J., concurring in part, dissenting in part).
69. H. Res. 917, 416th Sess. (Md. 2002).
70. See ETHICAL CONSIDERATIONS FOR REsEARCH ON HOUSING-RELATED HEALTH HAzARDs, supra note
19.
71. !d. at 2.
72. There is perhaps a growing awareness of the need to "democratize" research through community
participation. See GREENWOOD & LEVIN, supra note 20, at 175-78. Even the federal government is calling
for "Community-Based Participatory Research." In a recent request for proposals to establish multi-
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Of course, the researchers might see the report's recommendations and call for
a systems approach to research oversight in housing research as adding to the
costs for doing this type of research. The court is not unmindful of those costs,
but it is responding to what one might see as a major shift in "the political
equilibrium" in the market for knowledge creation about healthy housing. In
asserting a policy role in the urban healthy policy space, the court is engaging in
raising questions rather than providing answers. Some of the questions that might
need to be addressed in healthy housing research are:
• Under what circumstances would an urban community attempt less than full
abatement after Kennedy Krieger and the 10M reports on the ethics of this
type of research? The costs effectiveness of lead abatement is still an issue to
be resolved.
• Will the leaderShip for such efforts come from "social entrepreneurs" who
could garner the human and other resources to further research on the most
cost effective and ethical methods of creating healthy (not necessarily
lead-free) housing?
• Would such research necessarily involve some forms of "community
participatory action research?" 73
• Could the goal of preventing disability in children of low income coexist with
the goals of actors in the private market interested in "urban revitalization?"

Wholesale destruction of all the houses with lead paint; or for that matter, lead
pipes-"urban renewal"-is no longer viewed as a viable option for social
policy, particularly when there are tax incentives at the local, state, and federal
level for private investments in some, but not all, older urban neighborhoods.
Courts can in some situations perform an important health policy function by
effectively refrarning issues for both market actors and political institutions.

disciplinary centers to study health disparities, the funding agencies required that each center have at least
one project that develops, evaluates, or implements one such participatory action research project. See
Request for Application, Ctrs. for Population Health & Health Disparities, NIH, RFA: ES-02-009 (April
1, 2002), available at http://grants l.nih.gov/grants/guide/rfa-files/RFA-ES~02-009.html (last visited Nov.
9, 2008). At least one of the researchers involved with the lead paint reductions study in Grimes v.
Kennedy Krieger Institute, Farfel, appears to be involved as a technical consultant to a community based
group. Se.e Community Environmental Health Resource Center, Consultants and Advisors, http://
www.cehrc.org/about/consadv/index.cfm (last visited Nov. 9, 2008). Whether his involvement constitutes the kind of "participatory action research" as defined by Greenwood, however, cannot be
determined.
73. "Community-based participatory research" (CBPR) is defined as "collaborative approach to
research that equitably involves all partners in the research process and recognizes the unique strengths
that each brings. CBPR begins with a research topic of importance to the community, has the aim of
combining knowledge with action and achieving social change to improve health outcomes and eliminate
health disparities." See Community-Campus Partnerships for Health, http://depts.washington.edu/ccphl
cornmbas.htrnl (last visited Nov. 9, 2008).
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POLICY DEVELOPMENT VS. POLICY MAKING: DISEASE SURVEILLANCE AND
VACCINATION IN THE "NEW PuBLIC HEALTH"

Kennedy Krieger illustrates how courts can frame a question for society
without asserting that the court is the ultimate policy maker or even the
institutional framer of the issues for most urban health problems. Markets as well
as political and administrative institutions each have the capacity to become the
primary framing institution for health problems, depending on the context. Two
recent controversies--disease surveillance for diabetes in New York City and
legislation to make the Human Papillomavirus (HPV) vaccine mandatory for
girls-illustrate the need to distinguish between the role of policy development
and policy making in the health system. With this examination, we will be able to discern that the court in Kennedy Krieger was actually engaged in the process of
policy development within the overall health system.
A. The Health System and Chronic Disease Surveillance: the Case of Diabetes
New York City's disease surveillance system for diabetes at one level revives
the debate between proponents of the "old public health" and those who support
"new public health." 74 Those who frame the· growth rate of diabetes in these
terms often perceive major legal issues in terms of risks to privacy or liberty
interests and overall population health. 75 Within this framework, the question for
political institutions, in this case the New York City legislative body and its
public health authority, is whether a traditional public health law tool-creating
regulation that obliges health care providers to report patient informationshould be used for chronic diseases such as diabetes. The assumption is that if
surveillance was one of the legal tools used to reduce the incidence of infectious
diseases, legally mandated surveillance would probably be equally effective at
mobilizing the society to deal with the "epidemic" of diabetes.
This framing of chronic disease surveillance ignores the growing body of
knowledge that encourages systems-thinking in analysis of health problems. 76
Systems-thinking requires a concept of a health system that understands the

74. See supra note 21 and accompanying text.
75. Even critics of New York City's program frame the issues in terms of balancing. See Wendy K.
Mariner, Medicine and Public Health: Crossing Legal Boundaries, 10 J. HEALTil CAREL. & PoL'Y 121
(2007). The proponents of New York City's chronic diseases surveillance program simply strike a
· different balance. See, e.g., Lawrence 0. Gostin, "Police" Powers and Public Health Paternalism: HIV
and Diabetes Surveillance, HASTINGS CENrER. REP., Mar.-Apr. 2007, at 9.
76. The Institute of Medicine has been a pioneer in promoting a systems approach to the quality
problem in the health system starting with its reports on patient safety. See INsTITIJTE OF MEDICINE, To
ERR IS HUMAN: BUILDING A SAFER HEALTH SYSTEM, {Linda T. Kohen et al. eds., 2000) and COMMITTEE ON
QUALITY OF HEALTH CARE IN AMERICA, INSTITIJTE OF MEDICINE, CROSSING TilE QUALITY CHASM: A
HEALTH SYSTEM FOR TilE 21"' CENTURY NATIONAL ACADEMY PREss {2001). Even its recent reports on
problems involving research emphasize a systems approach. See, e.g., INsTITIJTE OF MEDICINE, ETHICAL
CONSIDERATIONS FOR REsEARCH INvOLVING PRISONERS (2006).
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differences and inteqelationship between the subsystems of public health and
health care delivery system. I propose the following schema as a starting point for
describing and providing an alternative approach to the problem of diabetes
management:

Health System

FIGURE.

Think of the health system as all of the things that might support the health of
individuals in a given society. At the basic level, we would know that the
availability of water, food, shelter, and caregivers for infants and children form
the components that suppo!-1 the health of a society. There are many factors
influencing how those various systems are organized. For instance in a
technologically advanced society such as ours, some might argue that our food
system is a factor in the rise in obesity. 77
We also know that public infrastructure such as sewer systems, immunizations
against infectious disease, and even parks and sidewalks influence the overall
level of health in a society or a community. 78 This is a starting definition of what
is pictured as the public health system in the graphic above. It does not
77. See, e.g., Adam Benforado, Jon Hanson, & David Yosifon, Broken Scales: Obesity and Justice in
America, 53 EMORY L.J. 1645, 1793-94 (2004). The authors argue that cheap- and subsidized com
production encourages the over-production of com, leading to the widespread use of cheaper com syrup
as a substitute for sugar in all kinds of goods. Rather than reduce the price of soda, for instance, cheaper
com syrup allows manufacturers of soda to increase the size of soda from seven ounces to twenty ounces.
78. Richard J; Jackson & Chris Kochtitzky, CENTERS FOR DISEASE CONTROL AND PREVENTION,
CREATING A HEALTHY ENVIRONMENT: THE IMPACT OF TiiE BUILT ENVIRONMENT ON PuBLIC HEALTH (200 1).
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necessarily matter that for a particular purpose the discussion of public health
"expands" from its traditional base and tries to engage the issue of whether it is
safe to use the park for walking under the systems view I propose. It would help
to point out, however, that there are legal limitations on the extent to which public
health officials can "mandate" that parks be safe. More important, this analysis
emphasizes the role of public health agencies in providing health data on issues
that are sometimes contentious, such as local smoking ordinances as part of the
prevention _function traditionally assigned to public health as a distinction from
health care delivery, particularly physicians, who "treat" diseases.
Our modem health care delivery system, however, has started to assume, at the
individual level, some of these traditional functions, like prevention or smoking
cessation. This blurring of the distinction between what is a public health
function and what is a health care delivery function occurs not because the health
care delivery system is necessarily more effective at prevention. Rather, the
blurring of the distinction is a result of the private and public investment in the
health care delivery system over time. Given the way health care delivery is
organized and financed, the resources that are counted as "health care costs" are
currently concentrated in the health care delivery system. For lawyers, it is
_ important to remember that the current structure of our health care delivery
system is not simply ·a reflection of "market forces" but also a function of the
incentives provided by the legal structure. 79
This systems view would allow us to reframe the efforts ofNew York CiW's
public health department to create more "effective" diabetes management by
delivering individual patient information to patients and their physicians as part
of the health care delivery system. The city seeks to achieve its public health goal
by requiring laboratories to report glucose levels to the public health department. 80 The hope is that when patients and physicians then receive information
indicating that diabetes management techniques have been ineffective, they will
be prompted to take positive steps toward "good" control. The city pi~oted this
program in the South Bronx, one of the most disadvantaged parts of New York
City, presumably on the theory that if it could work there, it could work
anywhere. 81
Given what we know about the factors influencing diabetes rates, I propose
that the Department confused its role as policy maker with its role as policy
developer. For a variety of reasons, diabetes management, even for the poorest of

79. See PoRTER & TEISBERG, supra note 29, at ch. 8. Chapter 8 has a bold list of reforms necessary to
change the health system including eliminating the notion that the physician are legally always
independent contractors-the "corporate practice of medicine doctrine."
80. I am deliberately ignoring the details of whether the patiept needs to consent to this transfer of the
information so passionately debated in the public health and bioethics literature. For a detailed account of
this debate, see sources cited supra note 17. I will also not address the question of whether the public
health exceptions in the HIPPA regulations are broad enough to exempt the public health department's
request for the electronic transfer of data.
81. Roll-out in South Bronx Planned, NYC Diabetes Newsletter, Issue 1, Spring 2007, at 1.
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our urban residents is a function that is now centered in the health care delivery
system. The actual capacity of publicly managed clinics and hospitals has been
dramatically reduced as public funds-Medicare and Medicaid-have been
shifted to hospitals, nursing homes, and other health care service providers. The
prominence of buzz words such as "public/private partnerships" and "new form
of health governance" to refer to health care delivery systems reflects this
dramatic change in the market for health services in recent years. To put it
bluntly, public health programs that encourage people with diabetes to exercise
without access to the most appropriate medications and professional knowledge
about diabetes management and risks seems a cruel joke.
The New York City program and its supporters might counter this critique by
pointing out that their program is aimed at the most disadvantaged communities 82
and will reach those individuals with access to the health care delivery system.
Furthermore, it helps those with diabetes who have not yet been diagnosed. The
surveillance approach of this program, however, seems to be based on the theory
that lack of knowledge is the main factor limiting good decisions, and that the
public health system can provide the needed knowledge to patients and their
physicians. This theory reflects the idea that data or knowledge automatically
drives policy.
Before other urban communities consider adopting the New York model, let
me propose an alternative use of our limited resources. The public health
department should have considered developing partnerships with a variety of
health care delivery practices in distressed areas in order to uncover the actual
barriers to "good" diabetes management in those populations. In addition, the
department should have examined whether or not it had the legal authority to
develop a c9mpetitive grant process that would encourage health care delivery
organizations to develop new ways to meet patient needs. · For instance,
healthcare practitioners may have been able to develop new ways of addressing
"diabetes self management" 83 using new technologies in a low-income community. There are a host of issues involved in diabetes self-management that range
from whether Medicaid will pay for daily testing to who will absorb the cost of
"diabetes educators."
Furthermore, there is another looming problem which has not been systematically studied in the inner city context, namely constraints on access to health care
delivery-as distinct from access to health insurance. Public health agencies, as
the sponsors of "organizational experiments," are well-positioned to stimulate
new professional analysis of how to effectively deliver health care. Indeed, these
agencies understand the fundamental problem of health care: that the outcome of
a service depends not simply on physician performance but also on how the
82. Goslin makes the point that it is cruel, especially on the HIVI AIDS front, to make sure that the
disadvantaged do not get the best treatments. See Gostin, supra note 75, at 10.
83. See generally Larry I. Palmer, LAW, MEDICINE, AND SOCIAL JUSTICE (Westminster/John Knox
Press) (1989).
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patient responds to his encounter with the health care delivery system. I propose
that the public health care system needs a new type of data that can only be
produced by comparing and contrasting the results of providing services to the
disadvantaged with the highest quality outcomes being produced in the arena of
diabetes management.
The disproportionate burden of diabetes on disadvantaged groups should not
blind us to the need for system level change or the need for lawyers to help
discover the legal barriers to more effective systems-functioning in the health
care delivery system. This means there will be a period of policy development to
discover the most effective methods of change, in contrast to old-fashioned
health policy which takes the form of rules and mandates. This will require
careful attention to how new knowledge is developed from data, and how to
protect the interests of the individuals involved. Accordingly, throughout this
process lawyers should ask themselves the following questions:
• Would comparative knowledge about actual "organizational performance"
encourage health .care providers to innovate as a means of achieving
"quality" improvements in chronic disease management?
• Is there a danger that the public costs, as presently measured, will lead to
mandatory disease management for the poor and those underserved by the
health care delivery system?
• What type of data about health care delivery organizations will make them
accountable to their patients and to the public?

B. Vaccine Policy in the Genomic Era: The HPV Vaccine

Only one state has made the new HPV vaccine "mandatory," despite intense
lobbying by various groups across the country, with financial support from the
vaccine manufacturer, Merck. 84 Political opposition to state legislation proposed
to require the vaccine became entwined with the debate over termination of
pregnancy and other female reproductive health practices. The interest group
analysis proposed by comparative institutional analysis scholars, 85 however,
instructs us not to dismiss these intense feelings or personal sensibilities as
non-scientific fears, as some commentators have done. 86 Rather, we should
examine the HPV vaccine debate in light of new market conditions that have
84. Vrrginia passed a law in early 2007 requiring mandatory vaccinations for girls entering the sixth
grade but also granted parents generous "opt-out" provisions. See VA. CooE.~Im. § 32.1-46 (2008). See
also Lawrence 0. Gostin & Catherine D ..DeAngelis, Mandatory HPV Vaccination: Public Health v.
Public Wealth, 297 JAMA 1921, 1921 (2007); Tim Craig, Kaine Says He'll Sign Bill Making Shots
Mandatory, WASH. PosT, Mar. 3, 2007, at B10; Stephanie Saul & Andrew Pollack, Furor on Rush to
Require Cervical Cancer Vaccine, N.Y. TiMEs, Feb.l7, 2007, at AI.
85. See KOMESAR, supra note 14.
86. See generally R. Alta Charo, Politics, Parents, and Prophylaxis-Mandating HPV Vaccination in
the United States, 356 NEW ENG. J. MED. 1905, 1905 (2007).
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changed vaccine development. The advent of genomics and the ability to
interrupt disease processes in new ways is one of those market forces. As I have
suggested elsewhere, the knowledge-creating enterprise, science, is itself an
important institutional force shaping the health care deli very system. 87 In
addition, the widespread use of patenting, even among university researchers, 88
will make vaccines relatively expensive initially as compared to earlier vaccines
such as polio. We should remember that Jonas Salk, inventor of one of the earliest
polio vaccines, refused to patent his discovery. 89 The strong emotions about HPV
on all sides of the political spectrum and the economics of new vaccine
development make it a good example of the "supply and demand of rights" in
health policy making. 90
Reframing the HPV vaccine debate in terms of institutional choice illustrates
the importance of having an interactive analysis of political processes and
courts-what I call "institutional balance." The primary focus of this interaction
thus far in the literature on mandatory vaccination is on the issue of whether
"religious exemptions" are constitutional. 91 As we move into the genomic era92
of vaccine development, it becomes apparent that market ·forces, including the
use of intellectual property law, have made more visible the issues of costs.
Courts may be called upon to decide a new constitutional issue: Are political
bodies that decide to enact mandatory vaccine laws required to provide indigents
free vaccines? The drafters of the only "mandatory" HPV vaccine law thus far
anticipated this possible "equality" claim by conditioning the effective date of the
mandate on the legislature appropriating adequate funds for indigent girls. 93 The
drafters of the law were undoubtedly aware that previously the political process
had neglected to provide such funding. The federal government established a
reimbursement program to the states in exchange for their enactment and
enforcement of federal vaccine regulations. 94 However, the existence of a federal
funding program does not mean that funds allocated for the vaccine program
necessarily meet existing needs 95 prior to the introduction of HPV. These issues

87. See PALMER, supra note 51, at ch.l. It is worth noting that the co-winner of the Nobel Prize in
Medicine or Physiology in 2008 was the person who discovered the HPV virus that causes cervical
cancer. See Press Release, The Nobel Assembly at Karolinska Institutet (Oct. 6, 2008), available at
http://nobelprize.org/nobel_prizes/medicine/laureates/2008/press.html (last visited Nov. 9, 2008).
88. See Amy R. Schofield, The Demise of Bayh-Dole Protections Against the Pharmaceutical
Industry's Abuses of Government-Funded Interventions, 32 J.L. MED. & ETiiiCS 777 (2004).
89. See Jonas Salk Biography, Academy of Achievement, available at http://www.achievement.org/
autodoc/page/salObio-1 (last visited Nov. 9, 2008).
90. See KoMESAR, supra note 14.
91. See, e.g., Gostin & DeAngelis, supra note 84, at 1922.
92. See Palmer, supra note 24.
93. See VA. CODE ANN.§ 32.1-46(A}(l2} (2008).
94. See Public Health Service Act, 42 U.S.C. § 247(b)) (West Supp. 2008); 42 C.F.R. § 51b.204
(2007).
95. See Grace M. Lee et a!., Gaps in Vaccine Financing for Underinsured Children in the United
States, 298 JAMA 638 (2007).
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of underlying costs led some proponents of a mandatory HPV vaccine to drop
their support when faced with the possible impact on an additional HPV mandate
on their state Medicaid budget. 96 This tradeoff between existing programs and a
proposed new program is not that unusual.
What is unusual concerning the Virginia mandatory HPV vaccine is the
manner in which "rights" were also part of the legislative tradeoffs. On its face,
the new statute adds HPV as one of the vaccines required for school attendance,
with respect to female students. However, additional statutory provisions create a
special exemption applicable only to HPV, allowing parents to opt out of the
mandate without claiming a religious or philosophical objection to vaccines as a
general matter. 97 This statutory exemption-a legislative "right"-illustrates ·
how the supply and demand for "rights" will likely play out along side the hidden
resources questions in the market for vaccines and government funding: Those
parents who both agree with the health benefits of HPV and have health resources
in the form of private insurance will have their daughters vaccinated.
Merck's extensive lobbying efforts for "mandatory" HPV vaccine laws in fact
were aimed at getting information about the vaccine to this particular group--the
willing insured. Merck is not naive enough to believe it· could overcome the
intensive opposition to laws that appear to condone or admit that teenagers might
be sexually active. Rather, the sponsorship of bills throughout the country could
be viewed as the first phase of its consumer advertising program for its vaccine in
advance of the arrival of a rival vaccine by a competitor. 98 On the other hand,
those parents with strong concerns about the health or moral risks of the HPV
vaccine are likely to opt out of the vaccine requirement, and, if indigent, are
unlikely to draw on public funds. If the parents who opt out are generally less
wealthy than those who obtain the vaccination, the net effect of this optimization
is that the "most vulnerable" will not receive the vaccine. 99 This disparity cannot,
unfortunately, be overcome through the enactment of mandatory vaccination
laws.
In any event, technological advances have in essence led to a transformation of
the meaning of the term "vaccine." Scientists are not simply trying to prevent the
transmission of diseases through person-to-person contact. HPV clearly is
infectious, but the "endpoint" of the HPV vaccine is the prevention of cervical
96. See, e.g., Laura Ungar, Requiring Vaccine for Ky Girls Unlikely, COURIER-JOURNAL, Mar. 7, 2007,
at l A (reporting that the bill requiring mandatory HPV vaccination is stalled in the Senate Appropriations
and Revenue Committee because of opposition to reopening the state budget).
97. See VA. CODE ANN.§ 32.1-46(0)(1) (2008).
98. See Merck Launches National Advertising Campaign for Gardasil®, Merck's New Cervical
Cancer Vaccine, Bus. WIRE, Nov. 13, 2006, available at http://findarticles.com/p/articles/rni_mOEIN/
is_2006_Nov_l3/ai_nl6836248/pg_l ?tag=artBody;coll (discussing Merck's extensive advertisement
campaign launched prior to the arrival of its competitor vaccine, GlaxoSrnithKlein's Cervarix®).
99. Cf Larry I. Palmer et al., Chemopreventive Drug Treatment in Subjects with Genetic Predisposition to Cancer: Prescriber.Liability and Health Care Disparities, 5 P!iARMACOGENOMICS 319 (2004)
(explaining how courts may use liability doctrines to raise questions about the intersection of health
disparities and medical technologies that may prevent certain kinds of cancers).
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cancer. The HPV vaccine symbolizes progress in the molecular understanding of
cervical cancer, and this progress is transforming the idea of "prevention." The
vaccine is thus one of several tools for prevention used by women. Other tools
include medical screenings such as the Pap smear and steps to decrease the risks
of transmission through sexual practices. These alternative forms of prevention
mean cervical cancer has a much greater impact in the less developed and
resource-constrained nations of the world than it does in the United States and the
industrialized West. This type of global disparity leads to a new question: Will
private actors such as the Bill & Melinda Gates Foundation become the
"knowledge entrepreneurs" who bring together pharmaceutical companies,
governments, and international financial institutions to establish subsidies for the
HPV vaccine, and who decide which countries to target? 100 Domestically, we
need to rethink the role of law-courts, legislatures, and administrative agencies
-in assuring access to public health measures such as vaccines, 101 while
struggling with the demand and supply of resources and rights. As we start to
consider these issues of access, we may find that courts will shift away from
"liberty" concerns to "equality" concerns in judging the constitutionality of
public health legislation. 102
IV.

URBAN HEALTH POLICY RESEARCH: PROFESSIONAL KNOWLEDGE,
CARDIOVASCULAR DISEASE RISK, AND RESEARCH

Nowhere is the framing of the issue in urban health policy by legal institutions
and lawyers more important than in cardiovascular disease. On the one hand, we
are bombarded with data indicating cardiovascular disease is the leading cause of
death in the United States, and presumably associated with individual behaviors
such as smoking, improper diet, and obesity. 103 In a simple model of health
policy where data drives policy, one would focus on determining which legal
tools would assist the public health prevention function. On the other hand, the
actual death rate from cardiovascular diseases in the United States has fallen
dramatically over ~he past quarter of a century, primarily due to a decrease in
risk-creating behaviors such as smoking, and due to innovations in treatment of

100. See, e.g., Sue J. Goldie eta!., Cost Effectiveness of HPV 16, 18 Vaccination in Brazil, 25 VACCINE
6257 (2007) (study was funded by the Bill & Melinda Gates Foundation).
101. The Virginia statute on immunization appears to grant the state board of health to enact
regulations to accord with the CDC recommendations in § 32.1-46: 'The required immunizations
... shall be those set forth in the State Board of Health Regulations for the Immunization of School
Children." VA. CoDE ANN. § 32.1-46(A) (2008). Even though in theory the State Board could have
enacted regulations requiring HPV, it was perhaps wise to let proponents go to the legislature for
mandatory HPV.
102. Cf Daniel Markovits, Quarantines and Distributive Justice, 33 J. L. MED. & ETHICS (2005)
103. ARlALDI M. MiNJNo ET AL., CTR. DISEASE CONTROL, DEATHS: FINAL DATA FOR 2004 (2007) (citing
cardiovascular disease as the leading cause of death in the United States).
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various forms of cardiovascular diseases. 104 As long we are reducing the risk
factors for cardiovascular disease and developing new and more effective
therapies, the age-adjusted death rate will continue to fall. Public health scientists
have concluded that the declining death rate is due in equal parts-50% each:--to
the reduction of risk factors and to new and more effective treatments. 105 One
therefore could draw the optimistic conclusion that current health policies are
moving us in the right direction. We could further assume that the health policy
process and law's role in that process are currently optimal for addressing the
complex problem of cardiovascular disease.
I propose two reasons for rejecting this optimistic view of the cardiovascular
disease health policy process. First, data about health outcomes in our current era
of evidence-based therapies cannot be evaluated without considering the looming
problem of costs in the health system. New therapies, and even the reduction of
risk factors in some cases, 106 initially are perceived as costly. For instance,
reducing the effects on air pollution lowers the risks of cardiovascular disease in
some populations, 107 but those reductions are often viewed as costly. Furthermore, the relatively new field of "medical economics" has begun to analyze the
relative cost effectiveness of various approaches to cardiovascular disease
treatment and management. 108 As the economic analysis of the cost of any
particular intervention becomes a part of the mainstream political discourse, a
legal framework without a space for cost analysis becomes more problematic.
Second, "health disparities" or "health inequities" are hidden in the overall
health outcome and cost figures used to describe "progress" in cardiovascular
diseases. There is a lot of data that informs us that the most vulnerable members ·
of our society, particularly in urban areas, are exposed to a greater share of the
burden of disease. It comes as no surprise, for instance, that some data suggests
an association between crime rates, unemployment, and cardiovascular disease. 109 More significant, it should come as no surprise that despite political and
scholarly rhetoric about eliminating health disparities, very little progress has
been made-by almost any measure--over the past decade. 110 Setting as a

104. See Earl S. Ford et al., Explaining the Decrease in U.S. Deaths from C(Jronary Disease,
1980-2000, 356 NEW ENG. J. MED. 2388 (2007).
.
105. ld.
106. See Barak D. Richman, Behavioral Economics and Health Policy: Understanding Medicaid's
Failure, 90 CoRNELL L. REv.705, 765-67 (2005) (describing the difficulties incorporating the true social
and psychological costs of preventative services into the Medicaid program in the states).
107. See Douglas W. Dockery & Peter H. Stone, Cardiovascular Risks from Fine Particulate Air
Pollution, 356 NEW ENG. J. MEn. 511 (2007).
108. See Daniel B. Mark & Mark A. Hlatky, Medical Economics and the Assessment of Value in
Cardiovascular Medicine: Part 11, 106 CIRCULATION 626 (2002).
109. See Kristina A. Sundquist et al., Neighborhood Violent Crime and Unemployment Increase the
Risk of Coronary Heart Disease: A Multilevel Study in an Urban Setting, 62 Soc. SCI. & MED. 2061
(2006).
110. See Rebecca Voelker, Decades of Work to Reduce Disparities in Health Care Produce Limited
Success, 299 JAMA 1411 (2008). See also M. Gregg Bloche, Health Care Disparities-Science, Politics,
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national goal "eliminating health disparities" by 2010 111 does not seem to lead to
measurable progress.
One response to the suggestion that "progress" in dealing with cardiovascular
disease has not dealt with the elephant in the room-health disparities-is simply
to call for more research to eliminate disparities. Presumably, if the professionals
in the health care delivery system knew more about the causes of the disparities
and the health professional workforce became more diverse, the diffusion of
professional knowledge throughout ·the health system would stimulate the
discovery and elimination of policy barriers to a more just distribution of the
burdens of disease. But even proponents of this view are starting to wonder about
the effectiveness of accumulating knowledge without a conceptual framework to
link an increase in knowledge with some type of policy process that is
accountable not only to the agencies funding health research, but also to those
individuals and communities that are most at risk. Increasingly, there are
calls-but not necessarily additional funding-for "community-participatory
action research" as a way to increase the effectiveness of the health equity
movement. 112 These quandaries about health disparities signal a failure to frame
a complex problem in a fashion that highlights the trade-offs involved and the
ethical dilemmas we need to address as citizen/lawyers. 113 The underlying ethical
dilemma I have identified in cardiovascular treatment and research is that we may
develop new treatments that improve overall health outcomes without addressing
the disparities in outcomes between the majority of Americans and those urban
populations that are most vulnerable.
Let me illustrate this point by sketching how different the policy questions
appear from my perspective by focusing on cardiovascular assist devices over
time. Dr. Denton Cooley's implantation of the first implantable artificial heart in
the late 1960s led to litigation over whether the patient/human subject had given
adequate "informed consent." 114 Regulatory oversight of the use of these new
devices grew out of the ethical concerns about the appropriateness of one
surgeon-admittedly a very skilled one-nonetheless being the sole decision
maker in using an experimental device. In addition, some proponents of
regulations hoped that supervised clinical trials could make these devices more
effective over time, even if their initial costs would be so high that few could

and Race, 350 NEw. ENG. J. MED. 1568 (2004) (indicating that political considerations can influence the
federal reporting of the health disparities data). ·
11~. Healthy People 2010, http://www.healthypeople.gov/About/goals.htm (last visited Nov. 9, 2008).
112. See generally CoMMUNITY-BASED PARTICIPATORY REsEARCH FoR HEALTH (MEREDITH MINKLER
ET AL. EDS., Jossey-Bass 2003).
113. A symposium of the William & Mary Law Review held on February 8-9, 2008 critically examined
the idea of the "citizen lawyer." See http://law.wm.edu/academics/intellectuallife/researchcenters/ibrU
pastevents/symposia/index.php (last visited December 15, 2008). The implications of how the
citizen/lawyer idea would change legal education were explored by one of the participants. See Edward
Rubin, The Citizen Lawyer and the Administrative State, 50 WM. & MARY L. REv. (forthcoming 2009).
114. See Karp v. Cooley, 493 F.2d 408 (5th Cir.l974).
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afford them. 115 This problem of equitable distribution of the benefits of
cardiovascular innovation was highly visible, at least to scholars in 1970s,
because of scarcity problems regarding human hearts for transplantation. 116
Fast forward a few decades and the ethical issues have been transformed by
technological progress in the effectiveness of heart assist technology as well as a
change in the institutional processes. The new regulatory environment for
medical devices seems to have eliminated the specter of a surgeon implanting a
heart device without any constraints. For a variety of reasons, not to be developed
here, the Food and Drug Administration required clinical trials. The AbioCor
implantable heart illustrates this practice, even though only eight patients were
approved for the first round of trials. The complex system of ethical review
established by the manufacture for these transplantation trials 117 further indicates
an acceptance of "ethics" as a part of the health policy process .
.A more significant change is the fact that the providers' "market"-manufacturers, physicians, and payers-has accepted the idea that a heart devices'
effectiveness should be determined through large scale "clinical trials" as defined
by epidemiologists rather than clinicians, the reporting of which has· to some
degree been professionalized by the establishment of standards for reporting
randomized clinical trials. 118 The implantable cardioverter defibrillator (ICD) is
an example of an assist device whose effectiveness in reducing the risk of heart
attack by monitoring and stimulating heart rhythms has been extensively studied.
The electronics and mechanics of ICDs have constantly improved and the risks of
implantation diminished over the past twenty-five years. Various manufacturers
now produce ICDs, with costs of a single implantation around $25,000. 119 Vice
President Cheney's highly publicized periodic check-ups of his ICD have helped
to make the avoidance of a heart attack part of the health policy discourse in this
country. 120
Recent randomized clinical trials have indicated the potential benefits of ICDs
for certain patients at risk of heart attacks. The Food and Drug Administration has
already approved the use of ICDs for those who previously suffered and survived
a heart attack. 121 But with a 38% mortality rate for U.S. heart attack victims (new

115. See SandeepJauhar, The Artificial Heart, 350 NEW ENG. J. MEo 542 (2004).
116. See generally GUIDO CALABRESI & PHiuP BoBBilT, TRAGIC CHOICES (1978).
117. See E. Haavi Morreim, The Case of the AbioCor Heart, HASTINGS CENTER. REP., JAN.-FEB. 2004,
at 11.
118. See http://www.consort-statement.org/ (last visited Dec. 15, 2008)
119. Mark A. Hlatky et al., Evidence-Based Medicine and Policy: The Case of Implantable Cardioverter Defibrillator, 24 HEALTH AFF. 42 (2005).
120. See, e.g., Cheney's Heart is Deemed Stable: Checkup Find No Problems, WASH. PosT, July 2,
2006, atA07; Cheney's Heart Device is Working Fine, WASH. PosT., July 9, 2003, atA02; Dana Milbank,
Cheney to Get Routine Heart Check, WASH. PosT, Sept. 13, 2002, at A04.
121. See http://www.fda.gov/bbs/topics/ANSWERS/2002/ANS01159.html (last visited Dec. 15,
2008).
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and recurrent), 122 we can imagine the pressure on conscientious clinical
researchers to expand the benefits of ICDs to those patients without prior heart
attacks. Medicare announced a new payment program for ICDs in the same issue
of the New England Journal of Medicine that announced the results of the latest
clinical studies. 123 Medicare conditioned its expansion of payments for some
patients who had not suffered a heart attack on the patient and physician's
willingness to become part of registry designed to assist further studies of
effectiveness. 124
There are three ethical and policy questions raised by this linkage of treatment,
costs, and increase in professional knowledge through clinical trials. First, a
Medicare regulatory rule that links payment to participation in the registry
appears unethical. Traditional thinking about access to health care frowns upon
this type of "bedside rationing." 125 Second, the potential cost of providing this
one device to all at-risk Medicare beneficiaries would require a large share of the
entire Medicare budget. In our current political paradigm of "health care cost
containment" and "no new taxes," a massive infusion of funds into the Medicare
budget is highly unlikely unless some other federal benefit is drastically
reduced. 126 Third, once ICDs are installed, we may be creating downstream
ethical dilemmas when these devices have to be turned off at the request of
terminally ill patients or their surrogates. 127 Our current way of linking the
federal public health payment system to the regulation of new devices leads to the
possibility that Medicare may pay for the implantation of the newest version of
the AbioCor implantable heart in patients who now are defined as "terminal." 128
A reframing of these questions from the institutional choice perspective argued
for here allows us to broaden the context of the debate. Widespread use of ICDs
indicates that prevention has become part of the health care delivery system's
approach t9 cardiovascular disease. Further, ICDs are only one of many data
points in judging overall reduction of risks of cardiovascular disease. Second,
and perhaps most significant, I propose that the over-emphasis on measuring
costs ignores the larger systemic issue of developing a method of measuring the

122. See Wayne Rosamond et al., Heart Disease and Stroke Statistics-2007 Update: A Report From
the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, 115 CIRCULATION e69; e89 (2007).
123. See Mark B. McClellan & Sean R. Tunis, Medicare Coverage of ICDs, 352 NEW ENG. J. MED.
222, 222-24 (Jan. 20, 2005).
124. See id.; A. Kadish, Prophylactic Defibrillator Implantation-Toward an Evidence-Based
Approach, 352 NEW ENG. J. MED. 285, 285-87 (Jan. 20, 2005).
125. See REsOLVING ETIUCAL DILEMMAS: A GUIDE FOR CLINICIANS 189-195 (3d ed. 2005).
126. Cf James F. Blumstein & Frank A. Sloan, Health Care Reform Through Medicaid Managed
Care: Tennessee (TennCare) as a Case Study and a Paradigm, 54 VAND. L. REv. 125 (2000)
127. See Rob Stein, Devices Can Interfere With Peaceful Death: Implants Repeatedly Shock Hearts
Of Patients Who Cannot Be Saved, WASH. PosT, Dec. 16, 2007, at AO 1.
128. See AbioCor Heart Moves Closer to Medicare Reimbursement, J. NEW ENG. ThCH., Feb. 4, 2008,
available at http://www.masshightech.com/stories/2008/02/04/daily4-AbioCor-heart-moves-closer-toMedicare-reimbursement.html (last visited Nov. 9, 2008).
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value to patients. The present methods of measuring effectiveness tell us how
much it costs to manufacture, install, and monitor an lCD in a variety of patients
with certain types of risks. We do not yet have robust methods of measuring the
"value-added" to patients of these innovations in heart technologies and disease
management. Were our studies more patient-centered rather than service
production centered, our public discourse would be more attuned to the
distribution of health benefits. 129 Were we more refined in our analysis of the
combined effects of risks factors and inadequate access to health care services in
many of our urban communities, we would probably pay more attention to
relative lack of progress in health outcomes among inner city dwellers. 130
Changing our thinking from cost to value to patient requires a three-step
process. The first step is to recognize that health is not a commodity, and neither
is health care. The second step is to recognize that costs are important in the type
of measurement I have proposed. Value is essentially the cost over a certain
period of time. Third, patients and their health providers need information about
the effectiveness of both interventions and preventive measures, as well as
information about available providers, in order to d~termine which course is best
for particular patients. The current system of accounting in health care develops
costs and effectiveness measures, but seld<;>m adds the relevant timeframe to the
equation.
Essentially, this three-step process reveals that our analysis of the health
system needs to be both more disease-specific and more population-specific.
Cardiovascular disease treatment and research would have a different set of
matrixes than certain kinds of cancers, for instance. Both disease areas deal with
risks and prevention, but the generalizing principle for the developments in each
area should be "value to patients," not necessarily "the costs" of producing the
treatment. Patients with chronic risks of heart attack may or may not understand
the need for ongoing quality improvements in treatments. Given this differential
in patient knowledge, the ethics of designing registries might involve a
community outreach function or the selection of centers with appropriate
diversity among its patient population. Further, the emphasis on value does not
mean there will not be competition built into the system.
But rather than compete over costs, the health system should compete over
value added to patients, adjusted for their risks. This could mean, for instance,
that those providers dealing with those at greater risks of cardiovascular disease
could fair better on the measurements than those dealing with lower risk patients.
A switch to a value basis of measurement of health outcomes would require a
radical reorganization of the payment system for health care where there are

129. My discussion of "the value to patients" as the center of analysis of the health care system is
based on my reading of PoRTER &TE!SBERG, supra note 29.
130. Cf David Satcher et al., What If We Were Equal? A Comparison of the Black-White Mortality
Gap in 1960 and 2000, 24 HEALTH AFF. 459 (2005) (describing how the disparities between blacks and
others have not changed significantly).
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incentives not for "prevention" per se, but for "value" added to patients.
Whatever the system of paying for health and health care, the system of
accountability of the overall system and its component parts must focus on value
to patients.
CONCLUSION

This analysis encourages us to reject commodity-thinking about public health,
health, and health care delivery. The latter may be a service whose outcome is
dependent upon both the actions of providers and clients. Those clients have
various concepts of health and levels of access to health care delivery and public
health infrastructure such as parks and safe sidewalks. 131 More important, those
clients live and work in diverse communities, whose social, economic, and
physical construction may impact the health of their members. 132
Defining health policy is critical in any context in which we seek to use
professional knowledge to move actors within institutional processes of the
overall health system, the government, and the market. Lawyers seeking to use
their particular skills in this multidisciplinary environment can use comparative
institutional analysis to frame the issue of institutional choice. They must
determine which of several imperfect institutions-"the markets," courts,
legislative bodies, and regulatory bodies-is the forum in which a particular
problem is currently being addressed before they can address the normative and
empirical question of whether the current choice is optimal. Most important,
comparative institutional analysis should equip lawyers to understand how the
legal system operating at various levels of government shapes the living
conditions and health of urban populations. It is my hope as a citizen-scholar133
that such an approach will better enable lawyers to frame the questions from the
perspective of those living in the most health risky communities in our cities.
This is, after all, what is meant by the phrase, "community participatory action
research." 134

131. See, e.g., Barak D. Richman, supra note 106.
132. See Nicholas Freudenberg et al., Beyond Urban Penalty and Urban Sprawl: Back to Living
Conditions as the Focus of Urban Health, 30 J. OF COMMUNITY HEALTH 1 (2005). See also Willian!
McGreevey et al., Propinquity Matters: How Better Health, Urbanization, and Income Grew Together,
1870-2008, 15 GEo. J. ON PoVERTY L. & PoL'Y X (2008).
133. See Joseph Goldstein, Psychoanalysis and Jurisprudence 77 YALE L. J. 1053-0n the Relevance
of Psychoanalytic Theory to Law, 23 PsYCHOANALYTIC STUD. Cmw 459 (1968) (discussing how legal
actors should approach problems in interdisciplinary spaces and encouraging us to distinguish our roles
as scholars and as citizens).
134. See GREENWooD & LEVIN, supra note 21.

